FDA Warning Letter — Cdymax (India) Pharma Private Limited
The FDA took a Warning Letter action against Cdymax (India) Pharma Private Limited on November 13, 2025 (Bangalore, India). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Cdymax (India) Pharma Private Limited
- Date
- November 13, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Bangalore (India)